EMA and HMA launch consultation on joint network strategy
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have launched a consultation into their joint network strategy … read more »
EMA removes scientific advice fees for some academic work
The European Medicines Agency (EMA) will work to encourage development of medicines for rare diseases by waiving the fees it … read more »
EMA launches 2019 annual report
The annual report of the European Medicines Agency (EMA) for 2019 has been released, giving insights into the work done … read more »
Analysis of EMA Q&A for medicinal products during the COVID-19 pandemic
MAP has been provided with an analysis of the EMA COVID-19 Q&A reported on recently. The European Commission recently published … read more »
NIH announces public-private partnership against COVID-19
The US National Institutes of Health (NIH) and Foundation for the NIH (FNIH) have launched a collaboration between industry and … read more »
EMA published Q&A on coronavirus regulatory requirements
In order to better explain the flexibilities introduced to manage the coronavirus pandemic, the European Commission (EC), European Medicines Agency … read more »
EMA publishes Regulatory Science Strategy to 2025
The European Medicines Agency (EMA) has launched its Regulatory Science Strategy to 2025 to ensure its regulatory work is optimised … read more »
Clinical Trials: Letter from the SME office of the EMA
The Small and Medium-sized Enterprises (SME) office of the European Medicines Agency (EMA) has written to stakeholders on the situation … read more »
EMA activates plans for health threats to support coronavirus work
The European Medicines Agency (EMA) has activated its plan for managing emerging health threats to support manufacturers of vaccines and … read more »
EMA publishes principles of electronic product information
The European Medicines Agency (EMA) has launched its principles explaining how EU Member States can work towards an international standard … read more »
